Dino Bekric
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer.
Journal: Expert opinion on emerging drugs
Published: June 03, 2026
Prognostic Factors in Patients with Peritoneal Mesothelioma Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis.
Journal: Annals of surgical oncology
Published: May 21, 2026
The importance of preclinical models for cholangiocarcinoma drug discovery.
Journal: Expert opinion on drug discovery
Published: January 22, 2025
Cannabidiol Is a Potential Inhibitor of Ferroptosis in Human Articular Chondrocytes.
Journal: Journal of cellular and molecular medicine
Published: October 24, 2024
The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells.
Journal: PloS one
Published: February 05, 2024
Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma.
Journal: Frontiers in cell and developmental biology
Published: October 11, 2023
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.
Journal: Translational oncology
Published: October 03, 2023
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.
Journal: Cancers
Published: January 05, 2023
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.
Journal: PloS one
Published: December 06, 2022
Last Updated: 09/26/2026